STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[6-K] Opthea Ltd Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2025

Commission File No. 001-39621

 

 

OPTHEA LIMITED

(Translation of registrant’s name into English)

 

 

C/- Prime Company Compliance, Level 9

505 Little Collins Street

Melbourne, VIC 3000

Australia

(Address of registrant’s principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒     Form 40-F ☐

 

 
 


EXHIBIT INDEX

 

Exhibit   

Description

99.1    Press Release – Quarterly Report and Cashflow


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.

 

OPTHEA LIMITED
(Registrant)
By:  

/s/ Jeremy Levin

Name:   Jeremy Levin
Title:   Chief Executive Officer

Date: October 31, 2025

Opthea Ltd

NASDAQ:OPT

OPT Rankings

OPT Latest News

OPT Latest SEC Filings

OPT Stock Data

524.82M
171.00M
4.52%
0.35%
Biotechnology
Healthcare
Link
Australia
Melbourne